Archived Insight | September 26, 2019

New Guidance on Enforcement of MHPAEA

On September 5, 2019, the federal departments implementing the Mental Health Parity and Addiction Equity Act (MHPAEA) — the Departments of Health and Human Services, Labor and Treasury (the Departments) —issued answers to Frequently Asked Questions (FAQs) regarding implementation of MHPAEA, the 21st Century Cures Act (Cures Act) and the SUPPORT for Patient and Communities Act (Support Act).

These FAQs make final previously proposed FAQ guidance issued by the Departments in 2018.

The Departments also issued a disclosure template that may be used to request mental health and substance use disorder benefit information from a plan.

New MHPAEA guidance Download Now

Questions about this update?

We're here to help. Get in touch. 

Speak with Us

See more insights

Male Therapist Encourages Distressed Male Veteran

MHPAEA Litigation and Enforcement News

See the Mental Health Parity and Addiction Equity Act (MHPAEA) litigation on hold and enforcement considerations, plus next steps for plan sponsors.

Health, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Architecture Engineering & Construction, Higher Education, Mental Health

Read Full Insight

Lawyer And Business Person Discussing In The Office

Supreme Court Addresses Prohibited Transaction Lawsuits

As a result of the Supreme Court’s decision, it will be easier for participants to sue plans for everyday plan transactions with service providers.

Retirement, Compliance, Multiemployer Plans, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Corporate

Read Full Insight

Pharmacist Taking Inventory With Digital Tablet

Executive Order Seeks to Lower Prescription Drug Prices

The order instructs federal departments to issue regulations or work with Congress to identify statutory changes necessary to address drug prices.

Health, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate

Read Full Insight

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.